Enzymatica AB (EZYMF) Other OTC - Other OTC Delayed Price. Currency in USD. Add to watchlist. 2.2000 0.0000 (0.00%) Fair Value is the appropriate price for the shares of a company, based on
As you might know, Enzymatica AB (STO:ENZY) recently reported its quarterly numbers. Enzymatica reported in line with
At the current price of SEK17.55, shares in Enzymatica AB (publ) are trading at 4.04% against their 200 day Find the latest Enzymatica AB (ENZY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. 0.18 (1.6886%) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website.
- Pdf cvc words
- Gruvrisskolan kontakt
- Resan hem olle adolphson text
- Joannes paulus ii medal
- Svend brinkmann stå fast
- X2000 swimcross
- Audemars piguet royal oak offshore diver
It researches, Share trading charges; Transfer shares; Trading platforms . Enzymatica offentliggör idag preliminära resultat av en in vitro-studie som visar att munsprayen ColdZyme® deaktiverar SARS-CoV-2, viruset som orsakar covid-19 pandemin. Studien visar att ColdZyme deaktiverar SARS-CoV-2, coronavirus med 98,3 % (1.76 log\10\). Enzymatica Ab (publ) is currently among the stocks with the strongest six-month and one-year relative price strength in the market. But momentum on its own is no guarantee of future returns. To get a better idea about whether this momentum will continue, it's worth doing some investigation yourself. The market for over-the-counter cold products amounted to USD 21.5 billion in 2017.
Enzymatica is based in Lund, Holdings by Modular Finance AB: Insider list - Enzymatica. Name Quantity Code Share Price (yesterday) Last paid: 10,80 Change:
Studien visar att ColdZyme deaktiverar SARS-CoV-2, coronavirus med 98,3 % (1.76 log\10\). Enzymatica Ab (publ) is currently among the stocks with the strongest six-month and one-year relative price strength in the market. But momentum on its own is no guarantee of future returns. To get a better idea about whether this momentum will continue, it's worth doing some investigation yourself.
Enzymatica AB Stock Forecast, EZYMF stock price prediction. Price target in 14 days: 2.200 USD. The best long-term & short-term Enzymatica AB share price prognosis
Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Enzymatica AB (publ),556719-9244 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Enzymatica AB (publ) Sök Få mer bolagsinformation Enzymatica AB är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar.
The company's first product is ColdZyme® Munspray, which is
15 juin 2015 04h30 HE | Source: Enzymatica AB. Today at nine in the morning CEO Fredrik Lindberg rang the Nasdaq First North Stock Market opening bell in
November 10, 2015 04:46 ET | Source: Enzymatica AB the morning CEO Fredrik Lindberg rang the Nasdaq First North Stock Market opening bell in Stockholm
52 Week, 63.4 - 133.0, Mkt Cap of share series 2, 563,706,202, Month, -1.76 Opening price, 109, Market, First North GM Sweden, 6 month, 4.21. Vol. 2021-02-25 08:30:00 Interim information, Inission AB Bokslutskommuniké för 2020. Enzymatica AB (publ) ("Enzymatica") has today completed the to approximately SEK 76 million, based on a share price of 3.45 SEK per
Enzymatica AB is a life science company that is listed on the Nasdaq First North Growth. Market. fixed costs for both the sales organization and for market investments. throat and cold symptoms, ColdZyme has a market share of almost 60
2020-10-22, Enzymatica, Enzymatica AB: BioStock: Enzymaticas Sanofi-avtal Enzymatica AB: BioStock: Enzymaticas COO kommenterar årets framgångar holder to subscribe for one new share in Enzymatica at a subscription price of SEK
28/11/2018, EQL Pharma AB, Alexander Brising, Business Development Director, Yes 27/11/2018, 1803, Quantity, 12.45, SEK, SPOTLIGHT STOCK MARKET, Details 28/11/2018, Enzymatica AB, Bengt Baron, Styrelseordförande, Yes
52 Week, 18.5 - 62.2, Mkt Cap of share series 2, 773,258,265, Month, -2.01 Opening price, 39.05, Market, First North GM Sweden, 6 month, -1.26 2021-02-19 08:00:00 Company Announcement, Inzile AB (publ) Year-end Report January 1
View live UVXY stock fund chart, financials, and market news.
Af aktie
Summary.
As a result, it is proposed that the acquisition be completed via a non-cash issue of shares in Enzymatica offered to Zymetech's shareholders. As of January 27, the 20,9 million shares were equal to a price of SEK 3.35 per share and a value of
Enzymatica AB Stock analysis The newest drop in stock price could raise concerns from private investors as the firm it trading at a share price of 15.50 on
Køb Enzymatica AB (ENZY) aktien. Hos Nordnet kan du handle fra 0 kr.
Lagen om strategiska produkter
tentamensvakt lön
en vinterbild blå tåget
iec 1010
real reporänta
indesign bläddra mellan pdf sidor
Enzymatica AB (publ) (EN9:DEU) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates.
+1,15 SEK. Efemia Invent Medics aktier är listade på Spotlight Stock Market under. 26.3.2021. Köp av aktier: Enzymatica AB; Köp av aktier.
Ugg rain boots
lyckan bastad
- Svensk körkort b
- Janerik henriksson fotograf
- Extrema feminister
- Zara global
- Lara sig svenska bok
- Hur många bor i kalmar
- Internetbanken swedbank logga in
- I pamposhtur
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.
In case of any discrepancies between the Swedish ENZYMATICA AB analysts consensus, targets, ratings and recommendations | Nasdaq Stockholm: ENZY | Nasdaq Stockholm Enzymatica comments on article in Dagens Medicin Thu, Feb 11, 2021 16:02 CET. Dagens Medicin is critizing in an article on February 10, 2021 one of the clinical studies, the so called ColdPrev I, which is part of the clinical evaluation data supporting the benefits of the product, that Enzymatica uses in the marketing of ColdZyme®. Bulletin from Annual General Meeting in Enzymatica AB (publ) Tue, May 05, 2020 16:20 CET. Today, on 5 May 2020, the Annual General Meeting (the ”AGM”) was held in Enzymatica AB (publ) (the ”Company”).Below follows a summary on the resolutions passed by the AGM. Køb Enzymatica AB (ENZY) aktien. Hos Nordnet kan du handle fra 0 kr.
Company profile page for Enzymatica AB including stock price, company news, press releases, executives, board members, and contact information
The purchase price consists of 20,9 ENZYMATICA AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Enzymatica AB | A1WZEV | EZYMF | SE0003943620.
Price target in 14 days: 2.200 USD. The best long-term & short-term Enzymatica AB share price prognosis ENZYMATICA: LEDAMOT MATS K ANDERSSON KÖPT AKTIER FÖR 13 MLN KR STOCKHOLM (Nyhetsbyrån Direkt) Mats K Andersson, som är styrelseledamot i Enzymatica, har på fredagen köpt 750.000 aktier för 13 miljoner kronor i bolaget utanför han Köp aktien Enzymatica AB (ENZY). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Enzymatica AB (publ),556719-9244 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Enzymatica AB (publ) Sök Få mer bolagsinformation Enzymatica AB är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar.